Evidence map›Paper›PMID 39937023›Full record

ArticleCells2025

Effect of Neutron Radiation on

Monika Szczepanek, Michał Silarski, Agnieszka Panek, Anna Telk, Katarzyna Dziedzic-Kocurek, Gabriele Parisi, Saverio Altieri, Ewa Ł Stępień

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Monika SzczepanekDoctoral School of Exact and Natural Sciences, Jagiellonian University, 30-348 Kraków, Poland.ORCID 0000-0002-9424-4051
Michał SilarskiFaculty of Physics, Astronomy and Applied Computer Science, M. Smoluchowski Institute of Physics, Department of Experimental Particle Physics and Applications, Jagiellonian University, 30-348 Kraków, Poland.ORCID 0000-0003-2206-0963
Agnieszka PanekDepartment of Biological Physics and Nanospectroscopy, Institute of Nuclear Physics, 31-342 Kraków, Poland.ORCID 0000-0002-3162-2668
Anna TelkDepartment of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Kraków, Poland.ORCID 0000-0003-1033-5317
Katarzyna Dziedzic-KocurekFaculty of Physics, Astronomy and Applied Computer Science, M. Smoluchowski Institute of Physics, Department of Medical Physics, Jagiellonian University, 30-348 Kraków, Poland.ORCID 0000-0002-1566-7217
Gabriele ParisiDepartment of Physics, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0001-5777-1269
Saverio AltieriDepartment of Physics, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0002-1376-3686
Ewa Ł StępieńFaculty of Physics, Astronomy and Applied Computer Science, M. Smoluchowski Institute of Physics, Department of Medical Physics, Jagiellonian University, 30-348 Kraków, Poland.ORCID 0000-0003-3589-1715

Funding

Narodowa Agencja Wymiany Akademickiej 03/01/2023Narodowe Centrum Nauki 2019/33/B/NZ3/01004Strategic Programme Excellence Initiative at the Jagiellonian University Anthropocene Priority Research Area U1U/P07/NO/17.13Strategic Programme Excellence Initiative at the Jagiellonian University DigiWorld Priority Research Area U1U/P05/NO/03.47Strategic Programme Excellence Initiative at the Jagiellonian University SciMat Priority Research Area RSM/31/SMStrategic Programme Excellence Initiative at the Jagiellonian University SciMat Priority Research Area U1U/P05/NW/03.23
6 · The paper itself

Abstract

Melanoma is an aggressive disease that arises from mutations in the cells that produce the pigment melanin, melanocytes. Melanoma is characterized by a high mortality rate, due to avoidance of applied therapies and metastasis to other organs. The peculiar features of boron neutron capture therapy (BNCT), particularly its cell-level selectivity, make BNCT a promising modality for melanoma treatment. However, appropriate cellular models should be used to study new therapies or improve the efficacy of existing therapies. Spheroids, which have been used for years for in vitro studies of the efficacy of anti-cancer therapies, have many characteristics shared with tumors through which they can increase the accuracy of the cellular response compared to 2D culture in vitro studies and reduce the use of animals for research in the future. To the best of our knowledge, when we started researching the use of spheroids in BNCT in vitro, there was no publication showing such use. Our study aimed to evaluate the efficacy of a 3D cellular model (spheroids) for testing BNCT on melanoma cells. We assessed boronophenylalanine (

Indexed as

Boron Neutron Capture TherapyMelanocytesMelanomaNeutronsSpheroids, CellularCell Line, TumorDNA DamageHumansboron neutron capture therapyboronophenylalanieDNA damageICP-MSmelanocytesmelanomaspheroidsthermal neutrons

Identifiers

PMID39937023
PMCPMC11816858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.